Search

everythinglearnresearchcommunity

for

Search:↓

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

Mononuclear cells may protect against certain chemotherapy-induced hair loss.

A girl with Evans' syndrome had her low platelet count successfully treated with zanubrutinib.

Adding hormone therapy to radiation improves survival for high-risk prostate cancer recurrence but has side effects.

The combination therapy is effective and well-tolerated for treating esophageal cancer.

Atorvastatin reversed memory problems caused by cancer drug trastuzumab and improved its cancer-fighting abilities without causing hair loss.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

Chemotherapy affects blood vessels in hair follicles, not stem cells, allowing hair regrowth.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

Bendamustine combined with rituximab is an effective and well-tolerated treatment for certain types of lymphoma.

Bexxar treatment led to a high response rate in patients with advanced-stage, treatment-resistant follicular lymphoma.

Combining UVB irradiation and anti-CD154 antibody improves hair follicle transplant survival.

Vismodegib is effective for basal cell carcinoma but has severe side effects.

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

Chemotherapy with carboplatin-paclitaxel causes hair loss in all patients.

Carboplatin-paclitaxel is preferred for advanced lung cancer due to its balance of affordability and patient well-being.

Donor lymphocyte infusions effectively treated leukemia relapse but caused vitiligo and alopecia areata.

The treatment was not recommended due to limited effectiveness and significant side effects.

Photobiomodulation therapy may speed up hair regrowth after chemotherapy in the short term.

Non-myeloablative stem cell transplants are a promising, less toxic option for older or weaker patients, with fewer side effects and good outcomes.

Ethanol embolization and debridement successfully treated a scalp AVM, stopped bleeding, and restored hair growth.

Capecitabine is as effective as intravenous treatments with fewer side effects, but requires careful management of Hand-foot syndrome and patient education.

FOLFOX6 chemotherapy effectively reduces VEGF levels and improves quality of life in advanced colorectal cancer patients.

Increasing ABC transporters in hair follicles may prevent chemotherapy-induced hair loss.

The cancer drugs bortezomib and lenalidomide cause skin side effects in many patients.

Chemotherapy and bone marrow transplant can cause permanent hair loss.

Antiviral drugs, especially daclatasvir, may be a new treatment for a rare skin disease, improving survival and reducing symptoms in mice.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Nurses are crucial in managing chemotherapy side effects for ovarian cancer patients to improve their quality of life.